Osteocyte Mechanotransduction and the Gabapentin-Sensitive Matrix-Channel Tethering Complex
骨细胞机械转导和加巴喷丁敏感基质通道束缚复合物
基本信息
- 批准号:10428360
- 负责人:
- 金额:$ 59.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-20 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AblationAcuteAddressAffinityAllelesAntiepileptic AgentsBehaviorBindingBiochemicalBiochemistryBiologicalBone MatrixBone ResorptionCalcium ChannelCell membraneCell surfaceCellsChronicClinicalCombined Modality TherapyComplexConfocal MicroscopyCuesDiseaseElementsFractureGeneticHeparan Sulfate ProteoglycanHistologicHormonalImageImpairmentIn VitroKnockout MiceLigandsLiquid substanceLoxP-flanked alleleMaintenanceMeasuresMechanicsMembraneMethodsMolecularMorbidity - disease rateMusMusculoskeletalOsteoblastsOsteoclastsOsteocytesOsteogenesisOsteopeniaPatientsPharmaceutical PreparationsPositioning AttributeProtocols documentationRegimenRehabilitation therapySignal TransductionSkeletonStructureSurface Plasmon ResonanceSystemTechniquesTimeTissuesWorkbonebone cellbone lossbone massbone qualitybone strengthdensitydentin matrix protein 1designdisabilityextracellularfracture riskgabapentingenetic approachin vivoinsightknock-downmechanical forcemechanical loadmechanical signalmechanical stimulusmechanotransductionmineralizationmouse modelnovelnovel strategiespainful neuropathyperlecanpharmacologicpreservationpreventreceptorresponsesedentary lifestyleside effectskeletaltransmission processvoltage
项目摘要
Project Summary
The skeleton relies on a variety of mechanical, biochemical, and hormonal cues to regulate bone strength,
structure, and mass. Osteocytes are both the most abundant and most mechanosensitive cells within bone.
Located deep in the bone matrix, these cells are optimally positioned to sense and respond to force, directing
the activity of other skeletal cells, including osteoblasts and osteoclasts. A variety of molecules influence
osteocyte mechanosensation; however, how force is directly transmitted from the mineralized matrix to the cell
membrane to induce a biological response remains unknown. We have identified the presence of a complex
within osteocytes composed of extracellular perlecan/HSPG2 and a cell surface subunit (a2d1) of voltage
sensitive calcium channels (VSCCs). As the perlecan-containing tethers bind the a2d1 subunit of VSCCs, this
Matrix-Channel Tethering Complex (M-CTC) enables direct connection between the mineralized matrix and the
cell membrane. Thus, the proposed studies will dissect how this mechanosensory complex mechanistically
regulates osteocyte behavior, under both basal and mechanical loading conditions. Additionally, the a2d1
subunit of the complex is the receptor for the commonly used antiepileptic and neuropathic pain drug,
gabapentin, which can have severe adverse skeletal side effects. Thus, this work will not only investigate the
foundational mechanisms through which osteocytes sense force, but will also inform the design of novel
strategies to offset the negative effects of gabapentin on bone that reduce bone mass.
Our overarching hypothesis is that perlecan-containing tethers, within the M-CTC, transmit force to the a2d1
subunit of VSCCs, enabling mechanical signals to be transduced into anabolic biochemical responses in
osteocytes.
Aim 1: Determine if osteocyte-specific disruption of the M-CTC membrane receptor a2d1 impairs basal
or load-induced bone formation with resultant loss in bone quality.
Aim 2: Determine if tissue-specific genetic ablation of the PLN matrix tethers within the M-CTC of
osteocytes impairs basal or load-induced bone formation with resultant loss in bone quality.
Aim 3: Determine how gabapentin interferes with the M-CTC to impair basal and load-induced bone
formation.
The function of the M-CTC has not been explored in vivo. As such, these integrated studies, designed to
genetically and pharmacologically disrupt the M-CTC and assess the functional consequences, will provide
basic insights into the relationship between extracellular tethers and calcium channels in bone. In the long
term, this understanding may reduce bone loss in patients treated with gabapentin for neuropathic pain.
项目总结
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Effects of Dietary Protein Source and Quantity on Bone Morphology and Body Composition Following a High-Protein Weight-Loss Diet in a Rat Model for Postmenopausal Obesity.
- DOI:10.3390/nu14112262
- 发表时间:2022-05-28
- 期刊:
- 影响因子:5.9
- 作者:Wright, Christian S.;Hill, Erica R.;Reyes Fernandez, Perla C.;Thompson, William R.;Gallant, Maxime A.;Campbell, Wayne W.;Main, Russell P.
- 通讯作者:Main, Russell P.
The bone-muscle connection in breast cancer: implications and therapeutic strategies to preserve musculoskeletal health.
- DOI:10.1186/s13058-022-01576-2
- 发表时间:2022-11-23
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William Roy Thompson其他文献
William Roy Thompson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William Roy Thompson', 18)}}的其他基金
Osteocyte Mechanotransduction and the Gabapentin-Sensitive Matrix-Channel Tethering Complex
骨细胞机械转导和加巴喷丁敏感基质通道束缚复合物
- 批准号:
10192665 - 财政年份:2018
- 资助金额:
$ 59.41万 - 项目类别:
Osteocyte Mechanotransduction and the Gabapentin-Sensitive Matrix-Channel Tethering Complex
骨细胞机械转导和加巴喷丁敏感基质通道束缚复合物
- 批准号:
9789654 - 财政年份:2018
- 资助金额:
$ 59.41万 - 项目类别:
Mechanical Partitioning of mTORC2 to Direct Mesenchymal Stem Cell Fate
mTORC2 的机械分区指导间充质干细胞的命运
- 批准号:
9099270 - 财政年份:2016
- 资助金额:
$ 59.41万 - 项目类别:
Role of mechanically activated Src/mTORC2 signaling on cytoskeletal adaptation
机械激活的 Src/mTORC2 信号对细胞骨架适应的作用
- 批准号:
8457722 - 财政年份:2013
- 资助金额:
$ 59.41万 - 项目类别:
Role of mechanically activated Src/mTORC2 signaling on cytoskeletal adaptation
机械激活的 Src/mTORC2 信号对细胞骨架适应的作用
- 批准号:
8601625 - 财政年份:2013
- 资助金额:
$ 59.41万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 59.41万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 59.41万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 59.41万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 59.41万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 59.41万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 59.41万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 59.41万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 59.41万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 59.41万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 59.41万 - 项目类别:
Operating Grants